Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by fossi_2002on Oct 03, 2023 10:42am
101 Views
Post# 35666759

Gilles is one tall tale - he has to go!!!

Gilles is one tall tale - he has to go!!!
Proph.... everything you told us here in the past months about the great phantansy in the different areas of Ceapro was a great collection of fairy tale narratives.

Although Gilles highlighted in the annual report that he sees "shareholder value" as one of his key points for 2023, the truth is now on the table.
Shareholders are losing their money and he gets his check ev
ery month.

Oats bet on the wrong horse. If he doesn't pull the ripcord now - when will he?
With Oats we have the majority of votes at the next AGM. Then Gilles is history! - and Proph... is too!

It is a shame that someone stands here and tells something about biotech index or other stocks that have also taken heavy losses.

We are shareholders of Ceapro and we don't need anyone to keep whitewashing the bad story.

The truth is: our investment is a catastrophe.

Gilles is one tall tale - he has to go!!!


<< Previous
Bullboard Posts
Next >>